806
Views & Citations10
Likes & Shares
In recent decades, some researchers assert that other newer lipid
measurements, including non-HDL-C, Apolipoprotein (Apo)A-I, Apob and lipid
ratios, are superior to traditional LDL-C in predicting adverse outcomes in
general population. Some researchers even suggest that Apob can replace the
standard “Lipid Profile” as a target for motoring and therapy in at-risk
patients. High plasma lipids interact with free radicals in human body leading
to develop coronary artery disease. We in this study have compared
hypolipidemic effects of fenugreek, Curcuma
longa and lemon. Study was conducted at Jinnah Hospital, Lahore, Pakistan
from January 2018 to May 2018. Ninety hyperlipidemic patients of age group 19
to 70 were included in the study. Exclusion criteria were diabetic, alcoholic
additives, hypertensive patients and those whose kidney or liver functions were
impaired. Consent was taken from all participants. Their base line lipid
profile was taken in Biochemistry Laboratory of the Hospital. They were divided
in three groups, i.e., 30 patients in each group. Group-I was advised to take
500 mg of Curcuma longa (haldi) mixed
in fresh milk without cream, thrice daily for two months. Group-II patients
were advised to take 100 grams of fenugreek leaves mixed with salad in each
meal (thrice daily) for the period of two months. Group-III patients were
advised to take 40 ml of fresh lemon juice mixed with 40 ml mineral water
thrice daily for two months. They all were advised not to take heavy meal rich
with any type of fat like junk food, etc. 1 h daily brisk walk was advised to
all participants. 15 days follow up visit was scheduled for them. After two
months their lipid profile was re-determined. When results were compiled and
statistically analyzed by applying paired ‘T’ test, it revealed that Curcuma longa decreased total
cholesterol, TG, LDL cholesterol 16.10, 20.01 and 17.59 mg/dl, respectively.
Fenugreek decreased total cholesterol, TGs and LDL cholesterol 14.70, 17.33 and
17.06 mg/dl, respectively. Lemon in two months therapy decreased total
cholesterol, TGs and LDL cholesterol 15.45, 10.13 and 11.97 mg/dl,
respectively. None of the above mentioned herbs raised HDL cholesterol
significantly. It was concluded from this research work that Curcuma longa, fenugreek leaves and
lemon are mild to moderately effective hypolipidemic herbs to lower total
plasma cholesterol, triglycerides and LDL cholesterol but have no potential to
raise HDL cholesterol when analyzed biostatistically.
Keywords: Curcuma longa, Fenugreek leaves, Cholesterol, Pakistani
kitchen spices, Gylcerides
INTRODUCTION
Atherosclerotic problems are encountered with
enhancement of LDL uptake by monocytes and macrophages [1,2]. In the liver,
uptake of plasma LDL is mediated via specific LDL receptors, but a scavenger
receptor system is employed by macrophages. Plasma LDL must be modified prior
to uptake by macrophages. Analysis of the lipid content in the oxidatively
modified LDL from hyper lipidemic patients revealed that the level of
lysophosphatidylcholine was greatly elevated, and the high level of the
lysolipid was shown to impair the endothelium-dependent relaxation of the blood
vessels [3-7]. In allopathy blood lipid levels are normalized
by statins, fibrates, niacin and bile acid binding resins (BABRs). All of these
allopathy related drugs have low compliance ranges from mild compliance due to
metalic taste of BABRs to
severe side effects like rhabdomyolysis by fibrates and statins [8].
Due to low compliance and adverse effects of conventionally used hypolipidemic
agents, herbal medicines are going to be famous among physicians and
cardiologists [9]. Medicinal herbs like Curcuma
longa, fenugreek and lemon contents are being used as mild to moderate
hypolipidemic agents. Curcuma longa
commonly known as haldi in India and Pakistan is used to lower plasma lipids,
in view of their contents. It contains curcuminoids (curcumin,
demethoxycurcumin and bisdemethoxycurcumin), turmerone, atlantone, zingiberene,
proteins and resins [10]. Curcumin reduces both the oxidation and circulation
of oxidized levels of LDL cholesterol which leads to reduction in the
occurrence or treatment of already present atherosclerosis in the subjects
[11]. Research has revealed that curcumin from turmeric is an extremely
efficient agent in increasing cholesterol uptake by the liver cells [12].
Several independent studies have shown that curcumin increases the expression
of cholesterol and lipoprotein receptors on the liver cells [13]. Curcumin also
increases cholesterol and bile acids excretion in feces [14]. Additionally,
curcumin also increases the amount of ABC (ATP-Binding Cassette) transporters.
These transporters are basically involved in flushing out excess cholesterol
from the inside of the macrophages. When the numbers of ABC transporters are
increased on the surface of a macrophage, the deposited cholesterol is effluxes
out through these channels again into the blood. Through the blood, it reaches
liver where it is metabolized efficiently [15]. The composition of fenugreek
includes a large number of chemical components. They include proteins and amino
acids, flavonoids, saponins and steroidal saponins, coumarin, lipids, vitamins,
minerals, galactomannan fiber and alkaloids, such as trigonelline. Extracts are
available standardized to contain 50% saponins or 20% of the amino acid
4-hydroxyisoleucine [16]. Treatment with fenugreek seed powder normalized the
enhanced lipid peroxidation and increased susceptibility to oxidative stress
associated with depletion of antioxidants [17]. The steroidal saponins
(diosgenin, yamogenin, tigogenin and neotigogenin) are thought to inhibit
cholesterol absorption and synthesis and hence its potential role in
arteriosclerosis [18]. Phenolics in Curcuma
longa have potential health benefits mainly due to their antioxidant
properties such as reactive oxygen species (ROS) scavenging and inhibition,
electrophile scavenging and metal chelation [19]. Epidemiological studies
support a relationship between the consumption of phenolic rich food products
and a low incidence of coronary heart disease, atherosclerosis, certain forms
of cancer and stroke [20]. Lipid peroxidation is inhibited by flavonoids and
flavonones present in lemon [21].
PATIENTS AND METHODS
Place and period of research work
The research work was
conducted at Jinnah Hospital, Lahore from January 2018 to May 2018 with
approval of Research Ethics Committee of the Hospital.
Sample size
Ninety hyperlipidemic
patients were selected for research work.
Consent
Written consent was taken
from all patients. specific performa was designed for the research work.
Hyperlipidemic patients were selected with age range from 19 to 70 years.
Exclusion criteria
Exclusion criteria were
hypertension, hypothyroidism, diabetes mellitus, alcohol addictive patients,
peptic ulcer, any gastrointestinal upset, renal impairment and any hepatic or
cardiac problem.
Grouping
All patients were divided in
three groups (Group-I, Group-II, Group-III), 30 patients in each group. Their
baseline lipid profile data were taken and filed in specifically designed
Performa, at start of taking medicine, like lipid profile, blood pressure and
pulse rate.
Lipid profile
Serum lipid profile (total
cholesterol, HDL-cholesterol, triglyceride) parameters were determined after a
12 h overnight fast by standard methods. LDL-cholesterol level was calculated
according to the Friedelwald’s formula. Thirty patients of Group-I were advised
to take 500 mg of Curcuma longa
(haldi) mixed in fresh milk without cream, thrice daily for two months.
Group-II patients were advised to take 100 g of fenugreek leaves mixed with
salad in each meal (thrice daily) for the period of two months. Group-III patients
were advised to take 40 ml of fresh lemon juice mixed with 40 ml mineral water
thrice daily for two months. They all were advised not to take heavy meal rich
with any type of fat like junk food, etc. 1 h daily brisk walk was advised to
all participants. 15 days follow up visit was scheduled for them. After two
months their lipid profile was re-determined.
STATISTICAL ANALYSIS
Mean values of the day-0 and
day-60 of tested parameters (total cholesterol, LDL cholesterol, triglycerides
and HDL cholesterol) ± SD were taken to be analyzed statistically. SPSS 10
Version 2.00.01.10 was used to analyze pretreatment and post treatment values
of all parameters. Paired ‘T’ test was applied to determine changes in pre and
post treatment values. P-value >0.05 was considered as non-significant
changes in tested parameters and P-values <0.01 were considered as
significant changes.
RESULTS
DISCUSSION AND CONCLUSION
1. Mwthy
HG, Strain JJ (2012) The ferric reducing ability of plasma (FRAP) as a measure
of “antioxidant power”: The FRAP assay. JJCM 12: 122-129.
2. Stensvold
I, Tverdal A, Solvoll K, Foss OP (1992) Tea consumption: Relationship to
cholesterol, blood pressure and coronary and total mortality. Prev Med 21:
546-553.
3. Solkth
R, Thorpe G (2012) Atherosclerosis: Newer view-points. JM 4: 90-95.
4. Serafini
M, Ghiselli A, Ferro-Luzzi A (1996) In
vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 50:
28-32.
5. Leenen
R, Roodenburg AJ, Tijburg LB, Wiseman SAA (2000) Single dose of tea with or
without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr
54: 87-92.
6. O'Reilly
JD, Sanders TA, Wiseman H (2000) Flavonoids protect against oxidative damage to
LDL in vitro: Use in selection of a
flavonoid rich diet and relevance to LDL oxidation resistance ex vivo? Free Rad Res 33: 419-426.
7. Balentine
DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev
Food Sci Nutr 37: 693-704.
8. Ito
T, Yoshida H, Ayaori M, Nishiwaki M, Yonemura A, et al. (2001) Conventional
hypolipidemic medicines and their compliance. Libyan J Nutr 66: 261-266.
9. Sesso
HD, Gaziano JM, Buring JE, Hennekens CH (2014) Hypolipidemic constituents in
herbs. J Epidemiol 149: 162-167.
10. Hodgson
JM, Puddey IB, Croft KD, Burke V, Mori TA, et al. (2014) Chemical contents of Curcuma longa. J Nutr 71: 1103-1107.
11. Klatsky
AL, Friedman GD, Armstrong MA (2012) Curcuma
longa affects LDL-oxidation. Med J Epidemiol 132: 479-488.
12. Hertog
MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D (1997) Antioxidant flavonols
and ischemic heart disease. Am J Clin Nutr 65: 1489-1494.
13. Kono
S, Shinchi K, Ikeda N, Yanai F, Imanishi K (2013) Miraculous hypolipidemic
herb: Curcuma longa. Jpn Prev Med 21:
526-531.
14. Fogelman
AM, Shechter I, Seager J, Hokom M, Child JS, et al. (2015) Curcuma longa inhibits enterohepatic circulation. J Surg Med Ind
77: 2214-2218.
15. Lowry
OH, Rosenbrough NJ, Farr AL, Randall RJ (2013) ATP-binding cassette transporter
and efflux of lipids. J Biol Chem 193: 265-275.
16. Keda
I, Imasato Y, Sasaki E, Nakayama M, Nagao H, et al. (2013) Chemical compounds
found in fenugreek seeds. J Biochem 1127: 141-146.
17. Yang
CS, Landau JM (2014) Handling LDL oxidation with herbal medicine. J Clin Nutr
130: 2409-2412.
18. Keli
SO, Hertog MG, Feskens EJ, Kromhout D (1996) Dietary flavonoids, antioxidant
vitamins and incidence of stroke. Arch Intern Med 156: 637-642.
19. Mukhtar
H, Ahmad N (2014) Metallic chelation by Curcumin. J Clin Med 71: 1698s-1702s.
20. Princen
HM, Van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, et al. (2014)
Phenolic compound rich foods for cure of Cad. J Health Med Ethiop 18: 833-841.
21. Hertog
MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D (2015) Lemon juice for
treating hyperlipidemia and Cad. J Ind Med 42: 1007-1011.
22. Wiseman
SA, Balentine DA, Frei B (2014) Antioxidant potential of pectin present in
herbs. J Med Ir 37: 705-718.
23. Tijburg
LB, Mattern T, Folts JD, Weisgerber UM, Katan MB (2014) Favonoids and
cardiovascular disease: A review. J Biol Pak 37: 771-785.
24. Gidez
LI, Miller GJ, Burstein M, Slagle S, Eder HA (2015) Moa of hypolipidemic herbs.
J Med Ther 23: 206-223.
25. Bingham
SA, Vorster H, Jerling JC, Magee E, Mulligan A, et al. (2015) Obesity,
hypercholestrelemia, metabolic syndrome and options of their cure. Med J Prev Med
78: 41-55.
26. Reaven
PD, Witztum JL (2013) Oxidized low density lipoproteins in atherogenesis: Role
of dietary modification. J Ethiop Med 16: 51-71.
27. Mattern
T, Witztum JL, Weisgerber UM (2012) Turmeric seeds oil interrupts enterohepatic
circulation of Bas. J Lipid Res 53: 2490-2514.
28. Geleijnse
JM, Launer LJ, Hofman A, Pols HA, Witteman JC (2014) How fenugreek is
antioxidant? Food Sci 159: 2170-2174.
29. Magee
E, Mulligan A, Constrv YL (2014) Consumption of foods rich in flavonoids is
related to a decreased cardiovascular risk. J Med Nutr 134: 23-26.
30. Jhumarr
J, Yulda C, Helov T (2013) Fruits can prevent diseases. MJN 8: 99-104.
31. Loversa
T, Mught R, Loferr T, Ilova H (2013) Phytochemistry of some plants. J Clin Nutr
Res 12: 44-48.
32. Hundahg
P, Urhav I, Ytrag R (2012) Therapeutic approach with medicinal herbs. JRMS 7:
66-80.
33. Sueawath
JJ, Howan RR, Mekba TG, Illahu RF, Ulkav BT (2015) Lemon is antioxidant fruit.
IJRM 7: 111-119.